GPT Healthcare Intrinsic Value
GPTHEALTH • Healthcare Services
Current Stock Price
₹115.31
Primary Intrinsic Value
₹23.06
Market Cap
₹922.5 Cr
-2.8%
Downside
Median Value
₹112.06
Value Range
₹23 - ₹112
Assessment
Trading Near Calculated Value
Safety Margin
-2.9%
GPTHEALTH Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹23.06 | ₹20.75 - ₹25.37 | -80.0% | Book Value/Share: ₹19.75, P/B: 1.0x |
| Simple DCF (5Y) | dcf | ₹112.06 | ₹89.65 - ₹134.47 | -2.8% | CF Growth: 15.0%, Discount: 15% |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
GPTHEALTH Intrinsic Value Analysis
What is the intrinsic value of GPTHEALTH?
Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of GPT Healthcare (GPTHEALTH) is ₹112.06 (median value). With the current market price of ₹115.31, this represents a -2.8% variance from our estimated fair value.
The valuation range spans from ₹23.06 to ₹112.06, indicating ₹23.06 - ₹112.06.
Is GPTHEALTH undervalued or overvalued?
Based on our multi-method analysis, GPT Healthcare (GPTHEALTH) appears to be trading near calculated value by approximately 2.8%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.89 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
Related Pages for GPT Healthcare
Additional stock information and data for GPTHEALTH
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2022 | ₹66 Cr | ₹64 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹43 Cr | ₹35 Cr | Positive Free Cash Flow | 8/10 |
| March 2020 | ₹42 Cr | ₹15 Cr | Positive Free Cash Flow | 7/10 |